Can SBC Maintain Q1's 67% Momentum? Q2 FY27 Earnings on Track
SBC Exports prints Q2 FY27 results on October 15 with strong order visibility. The garment-and-contract exporter is tracking its 40–50% full-year growth guidance after a stellar Q1 that saw revenue leap 67% YoY. Watch execution on recent Dubai orders and whether margins hold as the order book expands.
The Setup: Exceptional Q1, Now the Test
SBC Exports has delivered an exceptional Q1 FY27, with consolidated revenue surging 67.1% YoY to ₹121.08 Cr and net profit exploding 269.2% YoY to ₹9.60 Cr. The company is tracking its 40–50% growth guidance for full FY27, anchored by a recovering order book, repeat business from international clients (especially the Middle East and Dubai), and a recently extended ₹32 Cr contract with a major healthcare anchor. The question for Q2 is whether execution remains crisp and margins sustain as volumes scale.
~₹120–130 Cr
On-track with FY27 40–50% growth guidance; assumes similar traction to Q1
~₹9–10 Cr
Q1 achieved ~7.9% margin; expect similar range if execution steady
Strong
₹32 Cr BHU contract extension + recent ₹6.5 Cr Dubai order + repeat customer traction
40–50% FY27 growth
Requires consistent execution; Q2 will be the proof point
What's On-Plan vs. What Would Alarm
A strong print: Revenues in the ₹125–130 Cr range with net profit of ₹9.5–10.5 Cr would confirm that Q1 was no fluke and that the company is on track for 40–50% FY27 growth. Order execution on the Dubai garment supply and the BHU contract extension remains smooth, and margins hold. The trading window closure through October 15 suggests the board is comfortable with the narrative. A weak print: Q2 revenues below ₹115 Cr or profit below ₹8.5 Cr would raise questions about order execution timing and margin pressure. Any guidance pullback on the 40–50% FY27 growth target, or commentary on order delays, would reset sentiment sharply. At current valuation (₹64.18, RSI 88.2 overbought), the stock has priced in the momentum story—execution is now the gating factor.
Since Last Quarter: Filings & Key Events
Order momentum: The company received a repeat ₹6.5 Cr export order from Huxx Readymade Garments (Dubai) on September 4, reinforcing Middle East and GCC traction. The ₹32 Cr BHU (Banaras Hindu University) hospital contract was extended on July 2, securing a meaningful revenue pillar for FY27. Corporate actions: The company cancelled a previously approved preferential issue (loan-to-equity conversion of ~27.5 Mn shares) on August 12, a neutral event that simplifies the cap table. Ownership & blocks: FII shareholding ticked up 202 bps QoQ to 2.79% (Q1 FY27), the highest in 18 months. Block deals in early October show mixed activity: HRTI and Greenbucks rotate positions; Froxy sold 39.8 Mn shares on October 9. No promoter involvement; routine dealflow. Regulatory: Trading window closed from October 1 through 48 hours post-result (typical for earnings). The AGM was held on September 30; the Annual Report was filed. All routine.
1 · Revenue & Margin Trajectory
Can Q2 match or exceed the ~₹121 Cr revenue and ~7.9% margin from Q1? This will frame whether the 40–50% FY27 growth is realistic. Any margin compression due to order mix or input costs would be a red flag.
2 · Order Book Color & FY27 Guide Reaffirmation
Listen for management's commentary on the ₹32 Cr BHU contract, the Dubai order pipeline, and any demand signals from new geographies. Reaffirm or revise the 40–50% FY27 growth guidance. Any walkback would be negative.
3 · Valuation Reset Risk
At ₹64.18 (RSI 88.2 overbought, +164% off the 52-week low), sentiment is stretched. A mediocre print or cautious commentary could trigger profit-taking. Look for the stock's reaction to the numbers and guidance in the first 15 minutes post-release.
SBC Exports is in the sweet spot of a growth inflection: strong order book, repeat business from blue-chip international clients, and a full-year guidance (40–50% growth) that, if hit, would justify continued re-rating. Q1's 67% revenue surge and 269% profit jump set a high bar, but the underlying order visibility (₹32 Cr BHU + ₹6.5 Cr Dubai + others) suggests execution remains on track. The key risk is momentum—at current levels, the stock has priced in the narrative, and any stumble on margins, order timing, or FY27 guidance would be a sharp reset. Watch the numbers, the order commentary, and management's tone on growth sustainability.